therapeuticЮжно-Российский журнал терапевтической практикиSouth Russian Journal of Therapeutic Practice2712-81563033-8344РостГМУ10.21886/2712-8156-2023-4-4-22-29therapeutic-416Research ArticleОБЗОРЫREVIEWSНарушения проводимости и ритма сердца у больных ревматоидным артритомDisorders of cardiac conduction and rhythm in patients with rheumatoid arthritishttps://orcid.org/0000-0002-3463-7734РебровА. П.RebrovA. P.

Ребров Андрей Петрович - д.м.н., профессор, профессор кафедры госпитальной терапии лечебного факультета.

Саратов

Andrey P. Rebrov - MD, professor, professor of hospital therapy of general medicine Department, V.I. Razumovsky Saratov State Medical University.

Saratov

aprebrov@yandex.ruФГБОУ ВО «Саратовский государственный медицинский университет им. В.И. Разумовского» Минздрава РоссииРоссияSaratov State Medical University n.a. V. I. RazumovskyyRussian Federation202301122023442229Copyright © Ребров А.П., 20232023Ребров А.П.Rebrov A.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.therapeutic-j.ru/jour/article/view/416

В статье представлены данные о частоте и особенностях развития различных нарушений проводимости и ритма сердца у пациентов с ревматоидным артритом, механизмах развития этих нарушений, обсуждена роль воспаления, ремоделирования предсердий, дисфункции вегетативной нервной системы, активации ренин-ангиотензиновой системы, эндотелиальной дисфункции и других факторов.

The article presents data on the frequency and features of the development of various cardiac conduction and rhythm disorders in patients with rheumatoid arthritis, the mechanisms of development of these disorders, and discusses the role of inflammation, atrial remodeling, dysfunction of the autonomic nervous system, activation of the renin-angiotensin system, endothelial dysfunction and other factors.

ревматоидный артритвоспалениенарушения ритма сердцанарушения проводимостивнезапная сердечная смертьrheumatoid arthritisinflammationheart rhythm disturbancesconduction disturbancessudden cardiac deathReferencesLopez-Candales A, Hernández Burgos PM, Hernandez-Suarez DF, Harris D. Linking Chronic Inflammation with Cardiovascular Disease: From Normal Aging to the Metabolic Syndrome. J Nat Sci. 2017;3(4):e341. PMID: 28670620; PMCID: PMC5488800.Lopez-Candales A, Hernández Burgos PM, Hernandez-Suarez DF, Harris D. Linking Chronic Inflammation with Cardiovascular Disease: From Normal Aging to the Metabolic Syndrome. J Nat Sci. 2017;3(4):e341. PMID: 28670620; PMCID: PMC5488800.Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015;36(8):482-9c. DOI: 10.1093/eurheartj/ehu403Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015;36(8):482-9c. DOI: 10.1093/eurheartj/ehu403Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol. 1997;80(5B):10F-19F. DOI: 10.1016/s0002-9149(97)00477-3Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol. 1997;80(5B):10F-19F. DOI: 10.1016/s0002-9149(97)00477-3Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005;52(3):722-32. DOI: 10.1002/art.20878Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005;52(3):722-32. DOI: 10.1002/art.20878Masoud S, Lim PB, Kitas GD, Panoulas V. Sudden cardiac death in patients with rheumatoid arthritis. World J Cardiol. 2017;9(7):562-573. DOI: 10.4330/wjc.v9.i7.562Masoud S, Lim PB, Kitas GD, Panoulas V. Sudden cardiac death in patients with rheumatoid arthritis. World J Cardiol. 2017;9(7):562-573. DOI: 10.4330/wjc.v9.i7.562Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2017;38(22):1717-1727. DOI: 10.1093/eurheartj/ehw208Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2017;38(22):1717-1727. DOI: 10.1093/eurheartj/ehw208Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125(8):1043-52. DOI: 10.1161/CIRCULATIONAHA.111.023846Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125(8):1043-52. DOI: 10.1161/CIRCULATIONAHA.111.023846Karpouzas GA, Malpeso J, Choi TY, Li D, Munoz S, Budoff MJ. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis. 2014;73(10):1797-804. DOI: 10.1136/annrheumdis-2013-203617Karpouzas GA, Malpeso J, Choi TY, Li D, Munoz S, Budoff MJ. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis. 2014;73(10):1797-804. DOI: 10.1136/annrheumdis-2013-203617Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005;52(2):402-11. DOI: 10.1002/art.20853Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005;52(2):402-11. DOI: 10.1002/art.20853Goodson N, Marks J, Lunt M, Symmons D. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis. 2005;64(11):1595-601. DOI: 10.1136/ard.2004.034777Goodson N, Marks J, Lunt M, Symmons D. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis. 2005;64(11):1595-601. DOI: 10.1136/ard.2004.034777Van Doornum S, Brand C, King B, Sundararajan V. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(7):2061-8. DOI: 10.1002/art.21932Van Doornum S, Brand C, King B, Sundararajan V. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(7):2061-8. DOI: 10.1002/art.21932Mantel Ä, Holmqvist M, Jernberg T, Wållberg-Jonsson S, Askling J. Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome. Eur Heart J. 2015;36(48):3413-22. DOI: 10.1093/eurheartj/ehv461Mantel Ä, Holmqvist M, Jernberg T, Wållberg-Jonsson S, Askling J. Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome. Eur Heart J. 2015;36(48):3413-22. DOI: 10.1093/eurheartj/ehv461Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev. 2014;13(9):936-44. DOI: 10.1016/j.autrev.2014.05.007Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev. 2014;13(9):936-44. DOI: 10.1016/j.autrev.2014.05.007Kobayashi H, Kobayashi Y, Yokoe I, Kitamura N, Nishiwaki A, Takei M, et al. Heart Rate-corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab. J Rheumatol. 2018;45(12):1620-1627. DOI: 10.3899/jrheum.180065Kobayashi H, Kobayashi Y, Yokoe I, Kitamura N, Nishiwaki A, Takei M, et al. Heart Rate-corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab. J Rheumatol. 2018;45(12):1620-1627. DOI: 10.3899/jrheum.180065Lazzerini PE, Laghi-Pasini F, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A, et al. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes. Heart. 2017;103(22):1821-1829. DOI: 10.1136/heartjnl-2016-311079Lazzerini PE, Laghi-Pasini F, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A, et al. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes. Heart. 2017;103(22):1821-1829. DOI: 10.1136/heartjnl-2016-311079Cindas A, Gökçe-Kutsal Y, Tokgözoglu L, Karanfil A. QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol. 2002;31(1):22-6. DOI: 10.1080/030097402317255327Cindas A, Gökçe-Kutsal Y, Tokgözoglu L, Karanfil A. QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol. 2002;31(1):22-6. DOI: 10.1080/030097402317255327Chauhan K, Ackerman MJ, Crowson CS, Matteson EL, Gabriel SE. Population-based study of QT interval prolongation in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(1):84-9. PMID: 25572282; PMCID: PMC4366055.Chauhan K, Ackerman MJ, Crowson CS, Matteson EL, Gabriel SE. Population-based study of QT interval prolongation in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(1):84-9. PMID: 25572282; PMCID: PMC4366055.Adlan AM, Panoulas VF, Smith JP, Fisher JP, Kitas GD. Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis. J Rheumatol. 2015;42(3):421-8. DOI: 10.3899/jrheum.140861Adlan AM, Panoulas VF, Smith JP, Fisher JP, Kitas GD. Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis. J Rheumatol. 2015;42(3):421-8. DOI: 10.3899/jrheum.140861Lazzerini PE, Acampa M, Capecchi PL, Hammoud M, Maffei S, Bisogno S, et al. Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur J Intern Med. 2013;24(4):368-74. DOI: 10.1016/j.ejim.2013.02.009Lazzerini PE, Acampa M, Capecchi PL, Hammoud M, Maffei S, Bisogno S, et al. Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur J Intern Med. 2013;24(4):368-74. DOI: 10.1016/j.ejim.2013.02.009Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, et al. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford). 2014;53(1):131-7. DOI: 10.1093/rheumatology/ket338Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, et al. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford). 2014;53(1):131-7. DOI: 10.1093/rheumatology/ket338Lazzerini PE, Capecchi PL, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A, et al. Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis. Front Cardiovasc Med. 2016;3:31. DOI: 10.3389/fcvm.2016.00031Lazzerini PE, Capecchi PL, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A, et al. Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis. Front Cardiovasc Med. 2016;3:31. DOI: 10.3389/fcvm.2016.00031Villecco AS, de Liberali E, Bianchi FB, Pisi E. Antibodies to cardiac conducting tissue and abnormalities of cardiac conduction in rheumatoid arthritis. Clin Exp Immunol. 1983;53(3):536-40. PMID: 6352096; PMCID: PMC1535654.Villecco AS, de Liberali E, Bianchi FB, Pisi E. Antibodies to cardiac conducting tissue and abnormalities of cardiac conduction in rheumatoid arthritis. Clin Exp Immunol. 1983;53(3):536-40. PMID: 6352096; PMCID: PMC1535654.Kadi H, Inanir A, Habiboglu A, Ceyhan K, Koc F, Çelik A, Onalan O, Arslan S. Frequency of fragmented QRS on ECG is increased in patients with rheumatoid arthritis without cardiovascular disease: a pilot study. Mod Rheumatol. 2012;22(2):238-42. DOI: 10.1007/s10165-011-0493-9Kadi H, Inanir A, Habiboglu A, Ceyhan K, Koc F, Çelik A, Onalan O, Arslan S. Frequency of fragmented QRS on ECG is increased in patients with rheumatoid arthritis without cardiovascular disease: a pilot study. Mod Rheumatol. 2012;22(2):238-42. DOI: 10.1007/s10165-011-0493-9Jain R, Singh R, Yamini S, Das MK. Fragmented ECG as a risk marker in cardiovascular diseases. Curr Cardiol Rev. 2014;10(3):277-86. DOI: 10.2174/1573403x10666140514103451Jain R, Singh R, Yamini S, Das MK. Fragmented ECG as a risk marker in cardiovascular diseases. Curr Cardiol Rev. 2014;10(3):277-86. DOI: 10.2174/1573403x10666140514103451Guler H, Seyfeli E, Sahin G, Duru M, Akgul F, Saglam H, et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int. 2007;27(9):813-8. DOI: 10.1007/s00296-007-0307-8Guler H, Seyfeli E, Sahin G, Duru M, Akgul F, Saglam H, et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int. 2007;27(9):813-8. DOI: 10.1007/s00296-007-0307-8Arslan S, Bozkurt E, Sari RA, Erol MK. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease. Clin Rheumatol. 2006;25(3):294-9. DOI: 10.1007/s10067-005-0014-3Arslan S, Bozkurt E, Sari RA, Erol MK. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease. Clin Rheumatol. 2006;25(3):294-9. DOI: 10.1007/s10067-005-0014-3Pascale V, Finelli R, Giannotti R, Coscioni E, Izzo R, Rozza F, et al. Cardiac eccentric remodeling in patients with rheumatoid arthritis. Sci Rep. 2018;8(1):5867. DOI: 10.1038/s41598-018-24323-0Pascale V, Finelli R, Giannotti R, Coscioni E, Izzo R, Rozza F, et al. Cardiac eccentric remodeling in patients with rheumatoid arthritis. Sci Rep. 2018;8(1):5867. DOI: 10.1038/s41598-018-24323-0Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther. 2010;12(5):R171. DOI: 10.1186/ar3131Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther. 2010;12(5):R171. DOI: 10.1186/ar3131Kobayashi H, Kobayashi Y, Yokoe I, Akashi Y, Takei M, Giles JT. Magnetic Resonance Imaging-Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N-Terminal Pro-Brain Natriuretic Peptide Levels. Arthritis Care Res (Hoboken). 2017;69(9):1304-1311. DOI: 10.1002/acr.23138Kobayashi H, Kobayashi Y, Yokoe I, Akashi Y, Takei M, Giles JT. Magnetic Resonance Imaging-Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N-Terminal Pro-Brain Natriuretic Peptide Levels. Arthritis Care Res (Hoboken). 2017;69(9):1304-1311. DOI: 10.1002/acr.23138Suthahar N, Meijers WC, Silljé HHW, de Boer RA. From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Curr Heart Fail Rep. 2017;14(4):235-250. DOI: 10.1007/s11897-017-0343-ySuthahar N, Meijers WC, Silljé HHW, de Boer RA. From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Curr Heart Fail Rep. 2017;14(4):235-250. DOI: 10.1007/s11897-017-0343-yPatel KHK, Jones TN, Sattler S, Mason JC, Ng FS. Proarrhythmic electrophysiological and structural remodeling in rheumatoid arthritis. Am J Physiol Heart Circ Physiol. 2020;319(5):H1008-H1020. DOI: 10.1152/ajpheart.00401.2020Patel KHK, Jones TN, Sattler S, Mason JC, Ng FS. Proarrhythmic electrophysiological and structural remodeling in rheumatoid arthritis. Am J Physiol Heart Circ Physiol. 2020;319(5):H1008-H1020. DOI: 10.1152/ajpheart.00401.2020Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med. 2009;19(8):247-52. DOI: 10.1016/j.tcm.2010.02.005Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med. 2009;19(8):247-52. DOI: 10.1016/j.tcm.2010.02.005Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, et al. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ Res. 2009;105(5):462-70. DOI: 10.1161/CIRCRESAHA.109.196287Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, et al. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ Res. 2009;105(5):462-70. DOI: 10.1161/CIRCRESAHA.109.196287Morita N, Mandel WJ, Kobayashi Y, Karagueuzian HS. Cardiac fibrosis as a determinant of ventricular tachyarrhythmias. J Arrhythm. 2014;30(6):389-394. DOI: 10.1016/j.joa.2013.12.008Morita N, Mandel WJ, Kobayashi Y, Karagueuzian HS. Cardiac fibrosis as a determinant of ventricular tachyarrhythmias. J Arrhythm. 2014;30(6):389-394. DOI: 10.1016/j.joa.2013.12.008Tse G, Chan YW, Keung W, Yan BP. Electrophysiological mechanisms of long and short QT syndromes. Int J Cardiol Heart Vasc. 2016;14:8-13. DOI: 10.1016/j.ijcha.2016.11.006Tse G, Chan YW, Keung W, Yan BP. Electrophysiological mechanisms of long and short QT syndromes. Int J Cardiol Heart Vasc. 2016;14:8-13. DOI: 10.1016/j.ijcha.2016.11.006Qian Y, Fei Z, Nian F. The Association Between Rheumatoid Arthritis and Atrial Fibrillation: Epidemiology, Pathophysiology and Management. Int J Gen Med. 2023;16:1899-1908. DOI: 10.2147/IJGM.S406926Qian Y, Fei Z, Nian F. The Association Between Rheumatoid Arthritis and Atrial Fibrillation: Epidemiology, Pathophysiology and Management. Int J Gen Med. 2023;16:1899-1908. DOI: 10.2147/IJGM.S406926Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Svendsen JH, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ. 2012;344:e1257. DOI: 10.1136/bmj.e1257Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Svendsen JH, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ. 2012;344:e1257. DOI: 10.1136/bmj.e1257Kim SC, Liu J, Solomon DH. The risk of atrial fibrillation in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73(6):1091-5. DOI: 10.1136/annrheumdis-2013-203343Kim SC, Liu J, Solomon DH. The risk of atrial fibrillation in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73(6):1091-5. DOI: 10.1136/annrheumdis-2013-203343Bacani AK, Crowson CS, Roger VL, Gabriel SE, Matteson EL. Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. Biomed Res Int. 2015;2015:809514. DOI: 10.1155/2015/809514Bacani AK, Crowson CS, Roger VL, Gabriel SE, Matteson EL. Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. Biomed Res Int. 2015;2015:809514. DOI: 10.1155/2015/809514Argnani L, Zanetti A, Carrara G, Silvagni E, Guerrini G, Zambon A, et al. Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology. Front Med (Lausanne). 2021;8:745601. DOI: 10.3389/fmed.2021.745601Argnani L, Zanetti A, Carrara G, Silvagni E, Guerrini G, Zambon A, et al. Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology. Front Med (Lausanne). 2021;8:745601. DOI: 10.3389/fmed.2021.745601Beyer C, Tokarska L, Stühlinger M, Feuchtner G, Hintringer F, Honold S, et al. Structural Cardiac Remodeling in Atrial Fibrillation. JACC Cardiovasc Imaging. 2021;14(11):2199-2208. DOI: 10.1016/j.jcmg.2021.04.027Beyer C, Tokarska L, Stühlinger M, Feuchtner G, Hintringer F, Honold S, et al. Structural Cardiac Remodeling in Atrial Fibrillation. JACC Cardiovasc Imaging. 2021;14(11):2199-2208. DOI: 10.1016/j.jcmg.2021.04.027Li TYW, Yeo LLL, Ho JSY, Leow AS, Chan MY, Dalakoti M, et al. Association of Electrocardiographic P-Wave Markers and Atrial Fibrillation in Embolic Stroke of Undetermined Source. Cerebrovasc Dis. 2021;50(1):46-53. DOI: 10.1159/000512179Li TYW, Yeo LLL, Ho JSY, Leow AS, Chan MY, Dalakoti M, et al. Association of Electrocardiographic P-Wave Markers and Atrial Fibrillation in Embolic Stroke of Undetermined Source. Cerebrovasc Dis. 2021;50(1):46-53. DOI: 10.1159/000512179Narazaki M, Tanaka T, Kishimoto T. The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Expert Rev Clin Immunol. 2017;13(6):535-551. DOI: 10.1080/1744666X.2017.1295850Narazaki M, Tanaka T, Kishimoto T. The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Expert Rev Clin Immunol. 2017;13(6):535-551. DOI: 10.1080/1744666X.2017.1295850Tascanov MB. The Relationship Between Prolidase Activity and Atrial Electromechanical Changes in Patients with Paroxysmal Atrial Fibrillation. Comb Chem High Throughput Screen. 2019;22(1):69-75. DOI: 10.2174/1386207322666190306143317Tascanov MB. The Relationship Between Prolidase Activity and Atrial Electromechanical Changes in Patients with Paroxysmal Atrial Fibrillation. Comb Chem High Throughput Screen. 2019;22(1):69-75. DOI: 10.2174/1386207322666190306143317Meune C, Wahbi K, Assous N, Weber S, Kahan A, Allanore Y. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. J Rheumatol. 2007;34(10):2005-9. PMID: 17787044.Meune C, Wahbi K, Assous N, Weber S, Kahan A, Allanore Y. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. J Rheumatol. 2007;34(10):2005-9. PMID: 17787044.Alcalde Ó, Cabrera Gómez S, Vallès Gras E, Benito Villabriga B, Zuccarino F, Martí-Almor J. Rheumatoid Arthritis With Severe Atrial Fibrosis and Multiple Atrial Arrhythmias: Chronic Atrial Myocarditis? Rev Esp Cardiol (Engl Ed). 2018;71(5):396-397. (In English, Spanish). DOI: 10.1016/j.rec.2017.04.003Alcalde Ó, Cabrera Gómez S, Vallès Gras E, Benito Villabriga B, Zuccarino F, Martí-Almor J. Rheumatoid Arthritis With Severe Atrial Fibrosis and Multiple Atrial Arrhythmias: Chronic Atrial Myocarditis? Rev Esp Cardiol (Engl Ed). 2018;71(5):396-397. (In English, Spanish). DOI: 10.1016/j.rec.2017.04.003Bertelsen L, Diederichsen SZ, Haugan KJ, Brandes A, Graff C, Krieger D, et al. Left Atrial Late Gadolinium Enhancement is Associated With Incident Atrial Fibrillation as Detected by Continuous Monitoring With Implantable Loop Recorders. JACC Cardiovasc Imaging. 2020;13(8):1690-1700. Erratum in: JACC Cardiovasc Imaging. 2021;14(2):523-524. DOI: 10.1016/j.jcmg.2020.03.024.Bertelsen L, Diederichsen SZ, Haugan KJ, Brandes A, Graff C, Krieger D, et al. Left Atrial Late Gadolinium Enhancement is Associated With Incident Atrial Fibrillation as Detected by Continuous Monitoring With Implantable Loop Recorders. JACC Cardiovasc Imaging. 2020;13(8):1690-1700. Erratum in: JACC Cardiovasc Imaging. 2021;14(2):523-524. DOI: 10.1016/j.jcmg.2020.03.024.Ma J, Chen Q, Ma S. Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management. J Cell Mol Med. 2021;25(6):2764-2775. DOI: 10.1111/jcmm.16350Ma J, Chen Q, Ma S. Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management. J Cell Mol Med. 2021;25(6):2764-2775. DOI: 10.1111/jcmm.16350Bradham W, Ormseth MJ, Elumogo C, Palanisamy S, Liu CY, Lawson MA, et al. Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity. J Rheumatol. 2018;45(8):1078-1084. DOI: 10.3899/jrheum.170770Bradham W, Ormseth MJ, Elumogo C, Palanisamy S, Liu CY, Lawson MA, et al. Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity. J Rheumatol. 2018;45(8):1078-1084. DOI: 10.3899/jrheum.170770Chan YH, Chang GJ, Lai YJ, Chen WJ, Chang SH, Hung LM, et al. Atrial fibrillation and its arrhythmogenesis associated with insulin resistance. Cardiovasc Diabetol. 2019;18(1):125. DOI: 10.1186/s12933-019-0928-8Chan YH, Chang GJ, Lai YJ, Chen WJ, Chang SH, Hung LM, et al. Atrial fibrillation and its arrhythmogenesis associated with insulin resistance. Cardiovasc Diabetol. 2019;18(1):125. DOI: 10.1186/s12933-019-0928-8Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J Intern Med. 2017;282(1):64-75. DOI: 10.1111/joim.12626Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J Intern Med. 2017;282(1):64-75. DOI: 10.1111/joim.12626Adlan AM, Paton JF, Lip GY, Kitas GD, Fisher JP. Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. J Physiol. 2017;595(3):967-981. DOI: 10.1113/JP272944Adlan AM, Paton JF, Lip GY, Kitas GD, Fisher JP. Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. J Physiol. 2017;595(3):967-981. DOI: 10.1113/JP272944Zhao J, Chen M, Zhuo C, Huang Y, Zheng L, Wang Q. The Effect of Renin-Angiotensin System Inhibitors on the Recurrence of Atrial Fibrillation After Catheter Ablation. Int Heart J. 2020;61(6):1174-1182. DOI: 10.1536/ihj.20-346Zhao J, Chen M, Zhuo C, Huang Y, Zheng L, Wang Q. The Effect of Renin-Angiotensin System Inhibitors on the Recurrence of Atrial Fibrillation After Catheter Ablation. Int Heart J. 2020;61(6):1174-1182. DOI: 10.1536/ihj.20-346Braz NFT, Pinto MRC, Vieira ÉLM, Souza AJ, Teixeira AL, Simões-E-Silva AC, et al. Renin-angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis. Mod Rheumatol. 2021;31(1):119-126. DOI: 10.1080/14397595.2020.1740418Braz NFT, Pinto MRC, Vieira ÉLM, Souza AJ, Teixeira AL, Simões-E-Silva AC, et al. Renin-angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis. Mod Rheumatol. 2021;31(1):119-126. DOI: 10.1080/14397595.2020.1740418Khajeh Pour S, Scoville C, Tavernier SS, Aghazadeh-Habashi A. Plasma angiotensin peptides as biomarkers of rheumatoid arthritis are correlated with anti-ACE2 auto-antibodies level and disease intensity. Inflammopharmacology. 2022;30(4):1295-1302. DOI: 10.1007/s10787-022-01008-9Khajeh Pour S, Scoville C, Tavernier SS, Aghazadeh-Habashi A. Plasma angiotensin peptides as biomarkers of rheumatoid arthritis are correlated with anti-ACE2 auto-antibodies level and disease intensity. Inflammopharmacology. 2022;30(4):1295-1302. DOI: 10.1007/s10787-022-01008-9Corban MT, Godo S, Burczak DR, Noseworthy PA, Toya T, Lewis BR, et al. Coronary Endothelial Dysfunction Is Associated With Increased Risk of Incident Atrial Fibrillation. J Am Heart Assoc. 2020;9(8):e014850. DOI: 10.1161/JAHA.119.014850Corban MT, Godo S, Burczak DR, Noseworthy PA, Toya T, Lewis BR, et al. Coronary Endothelial Dysfunction Is Associated With Increased Risk of Incident Atrial Fibrillation. J Am Heart Assoc. 2020;9(8):e014850. DOI: 10.1161/JAHA.119.014850Bassu S, Zinellu A, Sotgia S, Mangoni AA, Floris A, Farina G, et al. Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study. Molecules. 2020;25(17):3855. DOI: 10.3390/molecules25173855Bassu S, Zinellu A, Sotgia S, Mangoni AA, Floris A, Farina G, et al. Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study. Molecules. 2020;25(17):3855. DOI: 10.3390/molecules25173855Akhmedov A, Crucet M, Simic B, Kraler S, Bonetti NR, Ospelt C, et al. TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodies. Cardiovasc Res. 2022;118(1):254-266. DOI: 10.1093/cvr/cvab005Akhmedov A, Crucet M, Simic B, Kraler S, Bonetti NR, Ospelt C, et al. TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodies. Cardiovasc Res. 2022;118(1):254-266. DOI: 10.1093/cvr/cvab005Iten L, Carroz P, Domenichini G, Graf D, Herrera C, Le Bloa M, et al. Tissu adipeux épicardique et fibrillation auriculaire [Epicardial adipose tissue and atrial fibrillation]. Rev Med Suisse. 2022;18(783):1048-1051. (In French). DOI: 10.53738/REVMED.2022.18.783.1048Iten L, Carroz P, Domenichini G, Graf D, Herrera C, Le Bloa M, et al. Tissu adipeux épicardique et fibrillation auriculaire [Epicardial adipose tissue and atrial fibrillation]. Rev Med Suisse. 2022;18(783):1048-1051. (In French). DOI: 10.53738/REVMED.2022.18.783.1048Fatma E, Bunyamin K, Savas S, Mehmet U, Selma Y, Ismail B, et al. Epicardial fat thickness in patients with rheumatoid arthritis. Afr Health Sci. 2015;15(2):489-95. DOI: 10.4314/ahs.v15i2.23Fatma E, Bunyamin K, Savas S, Mehmet U, Selma Y, Ismail B, et al. Epicardial fat thickness in patients with rheumatoid arthritis. Afr Health Sci. 2015;15(2):489-95. DOI: 10.4314/ahs.v15i2.23Szumilas K, Szumilas P, Słuczanowska-Głąbowska S, Zgutka K, Pawlik A. Role of Adiponectin in the Pathogenesis of Rheumatoid Arthritis. Int J Mol Sci. 2020;21(21):8265. DOI: 10.3390/ijms21218265Szumilas K, Szumilas P, Słuczanowska-Głąbowska S, Zgutka K, Pawlik A. Role of Adiponectin in the Pathogenesis of Rheumatoid Arthritis. Int J Mol Sci. 2020;21(21):8265. DOI: 10.3390/ijms21218265

The authors declare that there are no conflicts of interest present.